Name
Rosenthali Tervisekeskus OÜ
Registry code
10888995
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.08.2002 (22)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
1 516 000 €
3 090 €
0%
3 155 €
(estimate is approximate)
279 212 €
17
Submitted
No tax arrears
1%
0%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Anton Tärn 26.07.1989 (35) | 100% - 2 556.00 EUR | Board member | Direct ownership | |
| Svea Rosenthal 03.05.1957 (67) | - | - | - | Founder |
| 2019 21.03.2020 | 2020 30.03.2021 | 2021 25.03.2022 | 2022 03.05.2023 | 2023 22.04.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 864 214 € | 1 002 892 € | 1 118 798 € | 1 236 870 € | 1 516 000 € |
| Net profit (loss) for the period | 111 342 € | 105 475 € | 132 734 € | 176 186 € | 3 090 € |
| Profit Margin | 13% | 11% | 12% | 14% | 0% |
| Current Assets | 506 375 € | 428 377 € | 236 747 € | 359 149 € | 295 013 € |
| Fixed Assets | 53 160 € | 38 749 € | 481 953 € | 427 613 € | 414 056 € |
| Total Assets | 559 535 € | 467 126 € | 718 700 € | 786 762 € | 709 069 € |
| Current Liabilities | 78 584 € | 103 848 € | 103 066 € | 112 383 € | 154 857 € |
| Non Current Liabilities | - | - | 475 000 € | 375 000 € | 275 000 € |
| Total Liabilities | - | - | 578 066 € | 487 383 € | 429 857 € |
| Share Capital | - | - | - | - | - |
| Equity | 480 951 € | 363 278 € | 140 634 € | 299 379 € | 279 212 € |
| Employees | 14 | 16 | 15 | 19 | 17 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 101 048.19 € | 108 660.13 € | 19 |
| 2023 Q4 | - | 73 829.31 € | 79 546.04 € | 19 |
| 2023 Q3 | - | 94 346.58 € | 97 925.9 € | 18 |
| 2023 Q2 | - | 69 781.56 € | 75 174.6 € | 18 |
| 2023 Q1 | - | 77 418.26 € | 83 547.75 € | 19 |
| 2022 Q4 | - | 48 600.2 € | 52 543.48 € | 19 |
| 2022 Q3 | - | 48 454.25 € | 52 372.6 € | 19 |
| 2022 Q2 | - | 51 865.04 € | 53 384.62 € | 19 |
| 2022 Q1 | - | 73 787.69 € | 79 724.76 € | 20 |
| 2021 Q4 | - | 45 872.64 € | 49 572.19 € | 19 |
| 2021 Q3 | - | 51 575.29 € | 55 888.94 € | 20 |
| 2021 Q2 | - | 123 339.89 € | 62 429.32 € | 18 |
| 2021 Q1 | - | 78 926.53 € | 74 776.75 € | 17 |
| 2020 Q4 | - | 64 308.3 € | 53 518.48 € | 18 |
| 2020 Q3 | - | 53 434.9 € | 52 579.72 € | 22 |
| 2020 Q2 | - | 70 737.02 € | 62 437.98 € | 20 |
| 2020 Q1 | - | 56 975.16 € | 61 867.16 € | 19 |
